This brand name is authorized in Brazil, Croatia, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.
The drug GLYPRESSIN contains one active pharmaceutical ingredient (API):
1
|
UNII
4U092XZF0K - TERLIPRESSIN ACETATE
|
|
Terlipressin inhibits portal hypertension with simultaneous reduction of blood circulation in portal vessels. Terlipressin contracts smooth oesophageal muscle with consecutive compression of oesophageal varices. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| H01BA04 | Terlipressin | H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 521400302157318, 521418020006303 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 46-MEE-0114 |
| EE | Ravimiamet | 1186095, 1480441 |
| ES | Centro de información online de medicamentos de la AEMPS | 61412, 72359 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 031942, 088230 |
| GB | Medicines & Healthcare Products Regulatory Agency | 180249, 48250 |
| HK | Department of Health Drug Office | 36916, 61791 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-413434003 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 6871 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1019805, 1054751 |
| NL | Z-Index G-Standaard | 13487337 |
| NL | Z-Index G-Standaard, PRK | 90301 |
| NZ | Medicines and Medical Devices Safety Authority | 14932 |
| PL | Rejestru Produktów Leczniczych | 100147770, 100238684 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W43555001, W67158001 |
| SG | Health Sciences Authority | 07783P, 14244P |
| TN | Direction de la Pharmacie et du Médicament | 12883011H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8697621750364, 8697621790087 |
| ZA | Health Products Regulatory Authority | 43/21.13/0829 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.